Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity
Clinical trial NCT02118610 · COMPLETED
Trial details
- NCT number
- NCT02118610
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2018-12-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.